Ibrance (Palbociclib) for Advanced Breast Cancer
Ibrance (Palbociclib) is a breakthrough targeted therapy for advanced hormone receptor-positive (HR+), HER2-negative breast cancer. It represents a major advancement in modern oncology, helping thousands of patients live longer with better quality of life.
What is Ibrance?
Ibrance belongs to a class of drugs called CDK4/6 inhibitors. These enzymes are responsible for cell division and growth.
By blocking CDK4/6 activity, Ibrance helps stop cancer cells from multiplying, effectively slowing disease progression.
Indications
-
Treatment of advanced or metastatic breast cancer that is HR-positive and HER2-negative.
-
Commonly used in combination with hormonal therapies like Letrozole or Fulvestrant.
Administration and Dosage
-
Ibrance is taken orally (capsules).
-
The typical regimen: 21 days on treatment, followed by 7 days off each cycle.
-
Should be taken at the same time every day, with or without food, as prescribed by the physician.
Common Side Effects
-
Low white blood cell count (neutropenia).
-
Fatigue and weakness.
-
Nausea or loss of appetite.
-
Mild hair thinning.
-
Rarely: fever or liver enzyme changes.
Availability and Price in Egypt
Ibrance in Egypt is available in major oncology centers and specialized pharmacies. It is an expensive medication but may be accessible through patient-assistance or insurance programs.
Conclusion
Ibrance (Palbociclib) offers hope to patients with advanced breast cancer, effectively delaying disease progression and extending survival with manageable side effects. Despite its high cost, it remains one of the most impactful modern cancer treatments available in Egypt.
The medical information provided about Ibrance (Palbociclib) is for educational purposes only and does not replace professional medical advice. Always consult your doctor before making any treatment decisions.
If you’d like to know more about Ibrance in Egypt or book an oncology consultation, contact Macrocare today for:
-
Access to verified treatment centers.
-
Direct connection with experienced oncologists.
-
Ongoing patient support and guidance.
